Related Experiment Video
Updated: Dec 1, 2025

06:09
Quantification of Proteins Using Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry
Published on: July 31, 2011
23.3K
Mass Spectrometry-Based Solid Phase Peptide Reaction Assay for Detecting Allergenicity Using an Immobilized
Hiroshi Miyazaki1, Yasutaka Samejima2, Kazuya Iwata2
1Medical Device Division, Innovation and Business Development Headquarters, Daicel Corporation, Minato-ku, Tokyo 108-8230, Japan.
International Journal of Molecular Sciences
|November 11, 2020
Summary
A new mass spectrometry-based assay (M-SPRA) identifies skin sensitizers and peptide adducts. This method overcomes limitations of current assays, offering detailed chemical reactivity analysis for improved toxicology and risk assessment.
Area of Science:
- Toxicology and Environmental Health
- Analytical Chemistry
- Biochemistry
Background:
- Skin sensitization is a critical toxicological endpoint, driven by a sensitizer's ability to modify endogenous proteins.
- The direct peptide reactivity assay (DPRA) is an accepted in vitro method for assessing skin sensitization but has limitations with hydrophobic chemicals and detailed analysis.
- Existing methods struggle to analyze complex mixtures and provide in-depth mechanistic insights into sensitizer-protein interactions.
Purpose of the Study:
- To develop and validate a novel mass spectrometry-based solid-phase peptide reaction assay (M-SPRA) for skin sensitization assessment.
- To overcome the limitations of current reactivity assays, enabling detailed analysis of sensitizer-peptide adducts.
- To provide a more comprehensive understanding of chemical reactivity and binding mechanisms in toxicology.
Main Methods:
- Synthesis of peptides with photo-cleavable linkers immobilized on solid-phase resins.
- Reaction of sensitizers with immobilized peptides, followed by selective elution of peptide adducts after linker cleavage.
- Identification and quantification of sensitizers and peptide adducts using mass spectrometry.
Main Results:
- M-SPRA successfully identified sensitizers and their corresponding peptide adducts.
- The assay demonstrated the ability to analyze complex mixtures and provide detailed chemical reactivity information.
- Peptide adducts were selectively eluted, enabling accurate assessment of reaction products.
Conclusions:
- M-SPRA is a powerful tool for predicting skin sensitization, offering advantages over existing methods like DPRA.
- The assay provides detailed insights into chemical reactivity and sensitizer-peptide binding mechanisms.
- M-SPRA facilitates accurate assessment of both single components and mixtures, aiding toxicological evaluations and assay refinement.
Keywords:
alternative to animal testingimmobilizationmass spectrometrypeptidesphoto-labile linkerskin sensitizers
